AGP Wire

AGP

The global market for AI radiology tools is projected to rise to $3.69 billion by 2030, driven by precision medicine, cloud-based platforms and broader use of automated imaging workflows.

AGP

DarkSky International will host Under One Sky 2026 online Nov. 6-7, bringing together global experts to examine light pollution, space-based threats to the night sky and solutions ranging from safer lighting to astrotourism.

AGP

The Business Research Company says the Evarrest market is set for growth through 2035 as surgery volumes rise, hospitals expand, and surgeons look for faster bleeding control.

AGP

Global demand for Ebola preparedness is pushing the Ervebo vaccine market toward faster growth through 2035, according to The Business Research Company.

AGP

The Business Research Company says the AI-powered rare disease diagnosis market is set to surge from $2.56 billion in 2026 to $7.08 billion by 2030, driven by genetic testing, personalized medicine and faster clinical decision-making.

AGP

The market for AI-generated surgical prep checklists is projected to grow from $1.98 billion in 2025 to $2.43 billion in 2026, with North America leading and Asia-Pacific set to grow fastest.

AGP

The Business Research Company says demand for Euvichol and Euvichol-Plus is being lifted by rising liver disease rates, broader screening and higher healthcare spending.

AGP

The global AI oral health app market is projected to grow from $0.69 billion in 2025 to $1.8 billion by 2030, driven by telemedicine adoption, digital dental tools and rising demand for remote care.

AGP

The Business Research Company says the Draximage MAA market is set for steady expansion through 2035, driven by rising respiratory disease, lung cancer cases and broader use of nuclear imaging.

AGP

The Business Research Company says the epoetin alfa market is being lifted by chronic disease prevalence, more drug approvals and expanding biosimilar use. North America led the market in 2025, while Asia-Pacific is expected to grow fastest…

AGP

The Erwinaze/Spectrila market is projected to grow through 2035 as acute lymphoblastic leukemia cases rise, personalized medicine expands and more clinical trials support advanced therapies.

AGP

The Business Research Company says the Abevmy market is set for notable growth through 2035 as cancer cases rise and health systems push for lower-cost oncology treatments.

AGP

The market for AI-powered sleep apnea monitoring is projected to nearly double from 2026 to 2030 as demand grows for home-based diagnostics, wearable devices and remote sleep care.

AGP

Industry leaders, investors and technology providers will gather in Casablanca on 11-12 November 2026 for the 15th Africa Cementrade Summit.

AGP

The Business Research Company says the global Enspryng market is set to expand through 2035, driven by rising autoimmune and neurological diagnoses, broader biologics use, and stronger healthcare spending.

AGP

The Business Research Company says the global Epkinly market is set to grow through 2026-2035, led by rising demand for targeted oncology treatments and broader use of bispecific antibodies.

AGP

The artificial intelligence in oncology market is forecast to surge from $2.35 billion in 2025 to $10.25 billion by 2030, driven by rising cancer cases, precision medicine demand and wider use of AI in diagnostics and drug development.

AGP

The global aseptic sampling market is forecast to grow from $0.98 billion in 2025 to $1.09 billion in 2026, driven by biopharmaceutical expansion, tighter quality standards and more sterile processing.

AGP

The Business Research Company says the artificial intelligence clinical trial protocol feasibility tool market will grow from $0.83 billion in 2025 to $2.76 billion by 2030, driven by demand for faster trial approvals, lower costs and better…

AGP

The global market for artificial intelligence in life sciences is projected to rise from $3.59 billion in 2025 to $10.43 billion by 2030, according to a new report from The Business Research Company.